Project Details
Description
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Lucassin (Terlipressin) (REVERSE Trial)
| Status | Finished |
|---|---|
| Effective start/end date | 8/3/10 → 12/31/13 |
Funding
- IKARIA THERAPEUTICS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.